Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Senda Biosciences

Biotech & Life Sciences · Cambridge, United States · Founded 2017 Colt

Senda Biosciences | Pioneering Intersystems Biology

Valuation
$500M–1B
Latest valuation · 2026
Unlock exact value
Revenue
$10–50M
Latest reported FY
Unlock exact value
Headcount
<100
Current team size
Unlock exact value

Investors

12 investors on Senda Biosciences's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage
Series B+ 11 investors entered at this stage
Alexandria Venture Investments
Partners Investment
Qatar Investment Authority
Stage 1 Ventures
Mint Venture Partners
Terra Magnum Capital Partners
Longevity Vision Fund
Mayo Clinic
Samsung Life Science Fund
Bluwave Capital
State of Michigan Retirement Systems

Global footprint

Where Senda Biosciences has talent and traffic

Workforce by country
🇺🇸 United States · Cambridge HQ
Book a demo for the full country breakdown

Market sentiment

What the market is saying about Senda Biosciences

An AI-synthesized read of the highest-engagement posts about Senda Biosciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Senda Biosciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.